
Diabetic Retinopathy And Retinal Vascular Diseases
Abstract
According to WHO, the number of people living with diabetes has increased from 200 to 830 million in the past thirty-five years (since 1990). In 2020, more than a million people became blind due to diabetic retinopathy (DR), and almost 3.28 million suffered from moderate to severe visual impairment (MSI). DR is recognized as one of the most common causes of blindness and visual impairment among the working-age population worldwide. At the same time, early detection and treatment of MVI can reduce the risk of severe vision loss by approximately 90 percent.
The scientific novelty of the article is that it substantiates the need for a combination of anti-VEGF, glucocorticosteroids, laser therapy and systemic treatment, taking into account the pathogenesis features of a particular patient. Particular attention is paid to the development of prolonged forms of anti-VEGF delivery, including implants - a direction that has strategic importance in reducing the frequency of injections. The article emphasizes the relationship between molecular, inflammatory, hemodynamic and neurovascular mechanisms in the development of diabetic retinopathy.
Keywords
Diabetic retinopathy, diabetes mellitus (DM), hyperglycemia
References
T.P. Demicheva. " Diabetic retinopathy: epidemiological and organizational aspects, observation (literature review)"
E. N. Khomyakova. " Dynamics of the choroid of the ciliary body in pregnant women with diabetes in predicting the risk of DR"
Clinical practice, volume 15, no. 2 (07/15/2024).
https://clinpractice.ru/clinpractice/article/view/626630
Avanesova T.A., Oganezova Zh.G., Anisimova V.V., Baeva A.B., Miaev D.Kh. "Assessment of the prevalence of diabetic retinopathy using two-field mydriatic fundus photography"
Bulletin of Ophthalmology, No. 4 (2024).
E. Z. Kayalieva, S. R. Khalilova, V. B. Kaliberdenko. "Modern aspects of pathogenesis, diagnostics and treatment of diabetic retinopathy" Clinical analysis in general medicine No. 4 (2024), pp. 15–22.
Ling Dai, Bin Sheng, Tingli Chen, Qiang Wu, Ruhan Liu A deep learning system for predicting time to progression of diabetic retinopathy
https://www.nature.com/articles/s41591-023-02702-z
Jie Yang, Simon Fong, Han Wang Artificial intelligence in ophthalmopathy and ultra-wide field image: A survey
https://www.sciencedirect.com/science/article/abs/pii/S0957417421005091
Samir N. Patel, Angell Shi, […], and Michael A. Ultra-widefield retinal imaging: an update on recent advances
https://journals.sagepub.com/doi/full/10.1177/2515841419899495
By Uday Pratap Singh Parmar, Pier Luigi Surico, Rohan Bir Singh, Francesco Romano, Carlo Salati, Leopoldo Spadea, Mutali Musa Artificial Intelligence (AI) for Early Diagnosis of Retinal Diseases
https://www.mdpi.com/1648-9144/60/4/527
Bin Sheng, Xiaosi Chen, Tingyao Li An overview of artificial intelligence in diabetic retinopathy and other ocular diseases
https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2022.971943/full
by Charles Jit Teng Ong 1, Mark Yu Zheng Wong 1, Kai Xiong Cheong 1, Jinzhi Zhao 1, Kelvin Yi Chong Teo 1,2 and Tien-En Tan Optical Coherence Tomography Angiography in Retinal Vascular Disorders
https://www.mdpi.com/2075-4418/13/9/1620
Algorithms of specialized medical care for patients with diabetes mellitus. Edited by I. I. Dedov, M. V. Shestakova, A. Yu. 11th issue. Diabetes mellitus. 2023; 26 (2S): 1–157.
Article Statistics
Copyright License
Copyright (c) 2025 Laura Khachatrain

This work is licensed under a Creative Commons Attribution 4.0 International License.